Brett A. Pletcher - 10 Mar 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
EVP,Corp Affairs & Gen Counsel
Signature
/s/ Amy Kim by Power of Attorney for Brett A. Pletcher
Issuer symbol
GILD
Transactions as of
10 Mar 2022
Transactions value $
-$332,639
Form type
4
Filing time
14 Mar 2022, 21:46:01 UTC
Previous filing
13 Apr 2022
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +2.59K +7.96% 35.2K 10 Mar 2022 Direct F1
transaction GILD Common Stock Options Exercise +3.13K +8.9% 38.3K 10 Mar 2022 Direct F1
transaction GILD Common Stock Tax liability -$121K -2.09K -5.45% $57.92 36.2K 10 Mar 2022 Direct
transaction GILD Common Stock Sale -$212K -3.63K -10.04% $58.24 32.6K 11 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -2.59K -11.26% 20.4K 10 Mar 2022 Common Stock 2.59K Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -3.13K -15.32% 17.3K 10 Mar 2022 Common Stock 3.13K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.
F3 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.